Chenxi Xiang
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Research and Splicing
- Epigenetics and DNA Methylation
Papers in
-
- RNA modifications and cancer 3
- RNA Research and Splicing 2
- FOXO transcription factor regulation 1
- 14-3-3 protein interactions 1
-
- Lymphoma Diagnosis and Treatment 3
- Co-authors
- Tao Xi (7 shared papers)Lufeng Zheng (7 shared papers)Xiaoman Li (5 shared papers)Lanlan Gao (4 shared papers)Qianqian Guo (4 shared papers)Haiwei Ni (3 shared papers)Yufeng Xia (2 shared papers)Xinwei Guo (3 shared papers)
- Journals
- Journal of Hematology & Oncology (2 papers)Molecular Pharmaceutics (2 papers)Frontiers in Oncology (2 papers)Frontiers in Immunology (2 papers)The FASEB Journal (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Chenxi Xiang
20 papers receiving 400 citations
Peers
Comparison fields: 5 of 56
- Cancer Research 164
- Molecular Biology 252
- Cell Biology 52
- Oncology 75
- Pathology and Forensic Medicine 28
Countries citing papers authored by Chenxi Xiang
This map shows the geographic impact of Chenxi Xiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenxi Xiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenxi Xiang more than expected).
Fields of papers citing papers by Chenxi Xiang
This network shows the impact of papers produced by Chenxi Xiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenxi Xiang. The network helps show where Chenxi Xiang may publish in the future.
Co-authors
The 25 scholars most cited alongside Chenxi Xiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 112 | |
| 2 | 2019 | 58 | |
| 3 | 2017 | 50 | |
| 4 | 2018 | 34 | |
| 5 | 2015 | 29 | |
| 6 | 2017 | 23 | |
| 7 | 2017 | 20 | |
| 8 | 2023 | 18 | |
| 9 | 2023 | 11 | |
| 10 | 2020 | 11 | |
| 11 | 2024 | 9 | |
| 12 | 2020 | 8 | |
| 13 | 2022 | 5 | |
| 14 | 2023 | 4 | |
| 15 | 2021 | 3 | |
| 16 | 2024 | 2 | |
| 17 | 2022 | 2 | |
| 18 | 2025 | 1 | |
| 19 | 2025 | 1 | |
| 20 | 2023 | 1 |
About Chenxi Xiang
Chenxi Xiang is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 20 papers that have together received 402 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (5 papers), Cancer-related molecular mechanisms research (4 papers), Lymphoma Diagnosis and Treatment (3 papers), RNA modifications and cancer (3 papers), Viral-associated cancers and disorders (2 papers), RNA Research and Splicing (2 papers), FOXO transcription factor regulation (1 paper) and 14-3-3 protein interactions (1 paper). The work is most often cited by research in Cancer Research (164 citations), Molecular Biology (252 citations), Cell Biology (52 citations), Oncology (75 citations) and Pathology and Forensic Medicine (28 citations). Chenxi Xiang has collaborated with scholars based in China and United States. Frequent co-authors include Tao Xi, Lufeng Zheng, Xiaoman Li, Lanlan Gao, Qianqian Guo, Haiwei Ni, Yufeng Xia, Xinwei Guo, Zhiting Zhang and Yingying Xing. Their work appears in journals such as Journal of Hematology & Oncology, Molecular Pharmaceutics, Frontiers in Oncology, Frontiers in Immunology and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.